iCCA: a new diagnostic approach for a new therapeutic management! von Sabourin, J-C

Volltext

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy von Di Fiore, F, Blanchard, F, Charbonnier, F, Le Pessot, F, Lamy, A, Galais, M P, Bastit, L, Killian, A, Sesboüé, R, Tuech, J J, Queuniet, A M, Paillot, B, Sabourin, J C, Michot, F, Michel, P, Frebourg, T

Volltext

Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer von Di Fiore, F, Sesboüé, R, Michel, P, Sabourin, J C, Frebourg, T

Volltext

Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability von Miquel, C, Jacob, S, Grandjouan, S, Aimé, A, Viguier, J, Sabourin, J-C, Sarasin, A, Duval, A, Praz, F

Volltext

Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer von Andre, F., Cabioglu, N., Assi, H., Sabourin, J.C., Delaloge, S., Sahin, A., Broglio, K., Spano, J.P., Combadiere, C., Bucana, C., Soria, J.C., Cristofanilli, M.

Volltext

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin von Mitry, E, Baudin, E, Ducreux, M, Sabourin, J-C, Rufié, P, Aparicio, T, Lasser, P, Elias, D, Duvillard, P, Schlumberger, M, Rougier, P

Volltext

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 thera... von Ilie, M., Long-Mira, E., Bence, C., Butori, C., Lassalle, S., Bouhlel, L., Fazzalari, L., Zahaf, K., Lalvée, S., Washetine, K., Mouroux, J., Vénissac, N., Poudenx, M., Otto, J., Sabourin, J.C., Marquette, C.H., Hofman, V., Hofman, P.

Volltext

The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma: a judicious option? von Delaunoit, Th, Ducreux, M., Boige, V., Dromain, C., Sabourin, J.-C., Duvillard, P., Schlumberger, M., de Baere, T., Rougier, P., Ruffie, P., Elias, D., Lasser, P., Baudin, E.

Volltext

BRAF mutation in papillary thyroid carcinoma: Predictive value for long-term prognosis and radioiodine sensitivity von Zoghlami, A, Roussel, F, Sabourin, J.-C, Kuhn, J.-M, Marie, J.-P, Dehesdin, D, Choussy, O

Volltext

The KRAS mutation detection within the initial management of patients with metastatic colorectal cancer: A status report in France in 2011 von Lièvre, A, Artru, P, Guiu, M, Laurent-Puig, P, Merlin, J.L, Sabourin, J.C, Viguier, J, Bastie, A, Seronde, A, Ducreux, M

Volltext

Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs von Emile, J. F., Brahimi, S., Coindre, J. M., Bringuier, P. P., Monges, G., Samb, P., Doucet, L., Hostein, I., Landi, B., Buisine, M. P., Neuville, A., Bouché, O., Cervera, P., Pretet, J. L., Tisserand, J., Gauthier, A., Le Cesne, A., Sabourin, J. C., Scoazec, J. Y., Bonvalot, S., Corless, C. L., Heinrich, M. C., Blay, J. Y., Aegerter, P.

Volltext

TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy von Oden-Gangloff, A, Di Fiore, F, Bibeau, F, Lamy, A, Bougeard, G, Charbonnier, F, Blanchard, F, Tougeron, D, Ychou, M, Boissière, F, Le Pessot, F, Sabourin, J-C, Tuech, J-J, Michel, P, Frebourg, T

Volltext

Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours von Aparicio, T., Boige, V., Sabourin, J.-C., Crenn, P., Ducreux, M., Le Cesne, A., Bonvalot, S.

Volltext

Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours von Aparicio, T, Ducreux, M, Baudin, E, Sabourin, J.-C, De Baere, T, Mitry, E, Schlumberger, M, Rougier, P

Volltext

Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours von Baudin, E, Gigliotti, A, Ducreux, M, Ropers, J, Comoy, E, Sabourin, JC, Bidart, JM, Cailleux, AF, Bonacci, R, Ruffié, P, Schlumberger, M

Volltext

Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer von Meslin, F., Conforti, R., Mazouni, C., Morel, N., Tomasic, G., Drusch, F., Yacoub, M., Sabourin, J. C., Grassi, J., Delaloge, S., Mathieu, M. C., Chouaib, S., Andre, F., Mehrpour, M.

Volltext

Extensive molecular screening for hereditary non-polyposis colorectal cancer von Dieumegard, B, Grandjouan, S, Sabourin, J-C, Bihan, M-L Le, Lefrère, I, Bellefqih, Pignon, J-P, Rougier, P, Lasser, P, Bénard, J, Couturier, D, Paillerets, B Bressac-de

Volltext

Direct proportional relationship between endometrioma size and ovarian parenchyma inadvertently removed during cystectomy, and its implication on the management of enlarged endomet... von Roman, Horace, Tarta, Oana, Pura, Ioana, Opris, Ioana, Bourdel, Nicolas, Marpeau, Loïc, Sabourin, Jean-Christophe

Volltext

iCCA : une nouvelle approche diagnostique pour une nouvelle prise en charge thérapeutique von Sabourin, J.-C.

Volltext

Molecular characteristics of multifocal brain histiocytic sarcoma von Marguet, F., Piton, N., Adle‐Biassette, H., Renaud, F., Bohers, E., Boyer, T., Zarea, A., Derrey, S., Sabourin, J. C., Laquerrière, A.

Volltext